This study investigates pancreatic cancer. It explores the use of ctDNA methylation as a tool for diagnosis and monitoring.
The study evaluates the effectiveness of ctDNA methylation in identifying tumor-specific biomarkers for pancreatic cancer.
- Who can participate: Adults aged 18 to 80 years with suspected pancreatic malignancies identified through imaging, planning for surgical treatment or biopsy, with stable vital signs, and able to provide tissue and blood samples are eligible.
- Study details: Participants will provide blood and tumor tissue samples for analysis.